CEL-SCI Corporation (NASDAQ:CVM) shares are trading lower by 13.9% to $2.46 Friday morning after the company priced an offering of 3.875 million shares shares of its common stock at $2.00 per share, totaling $7.75 million before deductions.
The offering, expected to close on February 13, 2024, will fund the development of Multikine, general corporate purposes, and working capital. ThinkEquity is the sole book-running manager for the offering.
See Also: CEL-SCI Completes Commissioning of Its Multikine Manufacturing Facility for Commercial Scale Production of Head & Neck Cancer Drug
How To Buy CVM Stock
Besides going to a brokerage platform to purchase a share – or fractional share – of stock, you can also gain access to shares either by buying an exchange traded fund (ETF) that holds the stock itself, or by allocating yourself to a strategy in your 401(k) that would seek to acquire shares in a mutual fund or other instrument.
For example, in CEL-SCI’s case, it is in the Health Care sector. An ETF will likely hold shares in many liquid and large companies that help track that sector, allowing an investor to gain exposure to the trends within that segment.
According to data from Benzinga Pro, CVM has a 52-week high of $3.33 and a 52-week low of $1.04.
